Column

Inflammation: the sparkplug for chronic diseases

The results of an important clinical study show that canakinumab, a new anti-inflammatory medication, diminishes the risks of heart attacks and of lung cancer, confirming the essential role of inflammation in the development of these diseases. Download the column

23-Oct-2017 |

Tags: , , ,

Share this content!

Recent Articles

Why are mosquitoes so attracted to humans?
These bacteria that will redefine the concept of disease!
Obesity and colon cancer: a predicted pandemic among young adults
Vigorous exercise makes you smarter

Column Archives

Column Keywords

aging alcohol alzheimer anthocyanins antibiotics antibodies antioxydants bacteria basic science berries bladder blood blood vessels bone brain breast cachexia calories cancer cardiovascular disease chemotherapy children chocolate cholesterol chronic diseases coffee colon coronavirus COVID-19 crucifers cytokine dementia diabetes diagnostic diet digestive system drugs dyes eczema embolism endometrium environment eyes fasting fat fatigue female cancers fermentation fibers fish food fruit garlic genetics hair hearing heart heat high blood pressure immunity inactivity infertility inflammation interferon intestine junk food kidney larynx leukemia lifestyle liver lung lymphocytes male cancers Mediterranean diet medulloblastoma melanoma memory menopause metastasis metastasis microbiome mouth multiple sclerosis muscles nausea nervous system neurons nitrites nuts obesity oesophagus olive oil omega-3 oncogenic ovaries pain pancreas parkinson patient care physical activity physical exercise plants polyphenol prebiotics pregnancy prevention probiotics processed food prostate recurrence red meat red wine salt skin sleep smell soy spices stem cells stomach stress sugar sun supplements taste tea testicles therapy thrombosis thyroid tobacco turmeric uterus UV rays vaccines veganism vegetable vegetarianism virus vision vitamin D vitamin E weight women yogurt